CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Incentives and Support Programs to Improve Adherence to Tuberculosis Treatment

Last updated: February 18, 2021
Project Number: RC1318-000
Product Line: Rapid Response
Research Type: Non - Surgical Procedure
Report Type: Summary with Critical Appraisal
Result type: Report

Question

  1. What is the clinical effectiveness of adherence incentives and support programs in those who require assistance to complete their tuberculosis treatment?
  2. What are the evidence-based guidelines regarding the use of adherence incentives and support programs in those who require assistance completing their tuberculosis treatment?

Key Message

Three overviews of reviews and 11 systematic reviews were identified regarding the clinical effectiveness of adherence incentives in those who require assistance to complete their tuberculosis treatment.Four evidence-based guidelines were identified that provided recommendations regarding the use of adherence incentives in those who require assistance completing their tuberculosis treatment.The reported clinical effectiveness of adherence incentives for patients with tuberculosis was mixed. There were no detrimental effects of providing incentives, but there was also no conclusive evidence pointing to a clinical benefit. The overall quality of the included reviews was moderate to high.The included guidelines recommended that incentives and enablers be included as a part of a patient-centred strategy for treatment and for patients with active tuberculosis or patients at high risk; however, the evidence formulating these recommendations was of low certainty or quality. Two of the included guidelines were of high methodological quality, and 2 were of lower methodological quality.